Regent Pacific (575 HK)

Regent Pacific is an investment holding company focused on the healthcare and life sciences sectors. It engages in the research, development, manufacturing, marketing, and sale of pharmaceutical products for urological disorders, such as Fortacin™/Senstend™, and develops AI systems for biological aging clocks through Deep Longevity. The company was founded in 1991 and is headquartered in Central, Hong Kong.